VIB research tackles the bottleneck of time-resolved Cryo-EM 

New microfluidic device improves the time resolution of trEM almost tenfold.

Brussels, 18 August 2023 – Time-resolved cryo-electron microscopy (trEM) is a method to visualize how proteins function in time at near-atomic resolution. Although this method was pioneered in 1990, the potential of this technique has remained elusive because of two bottlenecks. One is the excessive consumption of proteins, and the other is that the time resolution is too low. Researchers from the lab of Prof. Rouslan Efremov of the VIB-VUB Center for Structural Biology developed a microfluidic device that tackles both issues. Their results were published in Nature Methods 

The difficulty of studying protein function 

Reconstructing the exact functioning of proteins is a challenge. Protein-related phenomena like ligand binding, protein-protein interactions, and charge exchange are dynamic processes that happen in a very short time frame. This makes it difficult to study the complex conformational transitions of proteins in detail. ​ 

Time-resolved cryo-electron microscopy (trEM) is a technique that helps unravel protein mechanisms by visualizing the structure of proteins while they function. The first step of trEM is initiating the reaction by flash photolysis or mixing, followed by stopping the protein reactions at sequential time points through plunge freezing. Although trEM is a high-potential technique, the established approaches have their limits. The time resolution for plunge freezing is limited to 100 ms or the amount of protein consumed is prohibitively high, making the technique difficult to apply in practice. ​ 

The lab of Prof. Rouslan Efremov at VIB-VUB Center for Structural Biology has now developed an instrument that tackles these bottlenecks. 

Elevating the trEM potential 

The team developed a microfluid device that combines a fast mixer and a spray generator. It encapsulates proteins in small droplets where the reaction is initiated by rapid mixing, then it uses a laser to create tiny bubbles which help to spray the samples onto grids that can be used for imaging. ​ 

Dr. Stefania Torino, first author of the study: “The precise mixing and spraying of the tiny droplets that contain the samples tackles both the bottlenecks – the amount of protein needed and the time resolution – that are hurdles for other techniques.” 

The researchers tested the device to study the dynamics of the GroEL:GroES protein complex. These proteins play an important role in helping other proteins fold properly, a highly dynamic process. With the help of their newly developed microfluid device, the team could successfully study the protein samples with a time resolution of 5 ms while consuming less than 100 nL of protein solution per EM grid. This is a massive, almost tenfold improvement over the earlier trEM technologies. ​ 

“Our new device makes trEM sample preparation potentially applicable for scarce proteins,” says Prof. Efremov. “The work does not end here. We envision that with further technical improvements to our setup, we will achieve a time resolution of below 1 ms.” 

Publication 

Torino et al. Time-resolved cryo-EM using a combination of droplet microfluidics with on-demand jetting. Nature Methods, 2023. 

 

 

Share

Latest stories

Website preview
Blocking lipid production in healthy lung cells can reduce lung metastasis
Leuven, 17 March 2026 - Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs. In two complementary studies published in Nature Cell Biology and Cancer Discovery, they show that tumors use lipids produced by lung cells as signals, and that decreasing the lipid production of lung cells can decrease metastasis. The findings point to new therapeutic strategies that target lung cell lipid production, rather than cancer cells themselves, which may also help refine patient selection for ongoing clinical trials targeting this pathway.
press.vib.be
Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be